Ponoi II Management, LLC
- SEC CIK
- 0001746488
- Latest filing
- Nov 14, 2022
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 4
- 0 vs. Q1 2022
- Portfolio value
- $36.8M
- −$8.26M (−18.3%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $16.7M | 45.2% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $13.4M | 36.3% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 327,123 | $4.14M | 11.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 145,401 | $2.65M | 7.2% | 00.0% | Unchanged | History |